Maxigen Biotech Inc (1783.TW) stock: key figures, P/E, revenue and dividend

Consumer Staples · Household Products · Taiwan · ISIN TW0001783009

Price
35.75 TWD
Market cap
3.20 bn TWD
P/E (2025)
12.08
P/S (2025)
3.95
Dividend yield
5.59 %
Net margin
32.69 %
Return on equity (ROE)
17.25 %
Return on assets (ROA)
14.01 %

Maxigen Biotech Inc financials

Fiscal year20242025
Revenue680.65 m TWD811.56 m TWD
Gross profit483.33 m TWD563.72 m TWD
Operating income194.38 m TWD261.04 m TWD
EBIT194.38 m TWD261.04 m TWD
Net income190.17 m TWD265.31 m TWD
Diluted EPS – continuing operations2.12 TWD2.96 TWD

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Maxigen Biotech Inc

Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical devices in Taiwan, America, Europe, rest of Asia, and internationally. It operates through two segments, Biomedical Products and Consumer Products. The company provides biomedical materials, such as collagen and bone supplements; beauty and skincare products; and medical devices for ophthalmology, otolaryngology, dental, surgical, orthopedics, electronic instructions for use, and medical aesthetics, as well as engages in collagen purification activities. It also offers ophthalmic viscoelastic under the PreviscAid, ViscAid, and BiVisc brands; intra-articular injections under the ArtiBest and ArtiAid brands; synthetic bone grafts under the BestAid, GingivAid, FormaGraft, and Foramic brands; and dermal filler injections under the Formaderm brand. In addition, the company provides collagen based regenerative matrixes comprising HealiAid, a collagen wound dressing; NasoAid, an intranasal splint; and FormaAid, a collagen membrane. Maxigen Biotech Inc. was incorporated in 1998 and is headquartered in Taoyuan City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.